News

Royal Philips today announced that it has signed an agreement to acquire Cardiologs, a company focused on transforming cardiac diagnostics using artificial intelligence and cloud technology.

Orlando, Fla.– November 8, 2021 – Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced results from an analysis of multiple studies that showed positive outcomes with its investigational...

The ControlRad device, approved for commercial cath lab use by the FDA in December 2020, is retrofitted to x-ray equipment in the catheterization lab. It creates a type of aperture, much like the aperture that controls the viewing area of a...

New industry report from WebCareHealth highlights strategies and opportunities for successful RPM implementation and adoption.

First patient dosed in trial investigating cardioversion of recent-onset atrial fibrillation.

Researchers at Karolinska Institutet in Sweden have examined long-term outcomes in patients who received pacemaker implantations after transcatheter aortic valve replacement through their groin. The result showed no significant difference in...

Cardiologists at The Ohio State University Wexner Medical Center and College of Medicine are the first in the United States to use a novel pulmonary neuromodulation system to treat patients hospitalized with acute decompensated heart failure...

The Veterans Health Administration has granted a contract to Massachusetts-based InfoBionic to provide remote cardiac monitoring and diagnosis services to our nation’s veterans.

Breakthrough CCM Therapy Now Being Implemented in China.